The different effects of cyclosporine and tacrolimus on lipid metabolism in renal transplant recipients

被引:0
|
作者
Wang, JD [1 ]
Ichimaru, N [1 ]
Takahara, S [1 ]
Kokado, Y [1 ]
Toki, K [1 ]
Permpongkosol, S [1 ]
Ding, X [1 ]
Nonomura, N [1 ]
Matsumiya, K [1 ]
Okuyama, A [1 ]
机构
[1] Osaka Univ, Sch Med, Dept Urol, Suita, Osaka 565, Japan
关键词
hyperlipidemia; cyclosporine; tacrolimus;
D O I
10.1097/00007890-199904150-00583
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
556
引用
收藏
页码:S145 / S145
页数:1
相关论文
共 50 条
  • [31] Switching from cyclosporine to tacrolimus in renal transplant recipients: impact on mycophenolic acid exposure
    Parant, F.
    Mtioui, N.
    Mazard, B.
    Gagnieu, M. C.
    Pouteil-Noble, C.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 537 - 537
  • [32] Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A
    Branten, AJW
    Hilbrands, LB
    van Hamersvelt, HW
    Koene, RAP
    Huysmans, FTM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (02) : 423 - 426
  • [33] Effect of conversion from cyclosporine to tacrolimus on cardiovascular risk profile in renal transplant recipients
    Do, Wonseok
    Kwon, Eugene
    Kim, Geun-Hee
    Lee, Kyung Hee
    Kim, Kyu Yeun
    Kim, Minjung
    Yang, Youngae
    Yim, Taehoon
    Hwang, Inryang
    Lee, Sukyung
    Jung, Hee-Yeon
    Choi, Ji-Young
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Chan-Duck
    TRANSPLANTATION, 2016, 100 (07) : S691 - S691
  • [34] Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients
    Loh, P. T.
    Lou, H. X.
    Zhao, Y.
    Chin, Y. M.
    Vathsala, A.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (05) : 1690 - 1695
  • [35] PHARMACOKINETICS OF TACROLIMUS IN RENAL TRANSPLANT RECIPIENTS
    Naik, Pradeep
    Mallikarjuna, M.
    Nayak, K. S.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S565 - S565
  • [36] Tacrolimus versus cyclosporine for lung transplant recipients in Portugal
    Teixeira Da Silva, David Tavares
    Dantas, Carolina
    Emiliano, Madalena
    Semedo, Luisa
    Cardoso, Joao
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [37] Hyperhomocysteinemia in renal transplant recipients with cyclosporine
    Kim, SI
    Yoo, TH
    Song, HY
    Hwang, JH
    Lee, HY
    Han, DS
    Moon, JI
    Kim, YS
    Park, KI
    Paeng, KJ
    Choi, KH
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1878 - 1879
  • [38] LATE EFFECTS OF CYCLOSPORINE AND FK506 ON LIPID-METABOLISM IN LIVER-TRANSPLANT RECIPIENTS
    MOR, E
    ATILLASOV, E
    KREIZMAN, I
    KOLESNIKOV, V
    MORAN, V
    SCHWARTZ, B
    SHEINER, PA
    SCHWARTZ, ME
    MILLER, CM
    BERK, P
    HEPATOLOGY, 1994, 20 (04) : A123 - A123
  • [39] THE EFFECTS OF CYCLOSPORINE AND PREDNISONE ON SERUM-LIPID AND (APO)LIPROPROTEIN LEVELS IN RENAL-TRANSPLANT RECIPIENTS
    HILBRANDS, LB
    DEMACKER, PNM
    HOITSMA, AJ
    STALENHOEF, AFH
    KOENE, RAP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 5 (12): : 2073 - 2081
  • [40] Concentration-dependent effect of cyclosporine on plasma lipid in renal transplant recipients
    Xu, F
    Wu, ZH
    Zhan, ZY
    Zou, HQ
    CLINICAL NEPHROLOGY, 1998, 50 (01) : 67 - 68